1. Coleman RE. 2006; Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 12(20 Pt 2):6243s–9s. DOI:
10.1158/1078-0432.CCR-06-0931. PMID:
17062708.
3. Hird A, Zhang L, Holt T, Fairchild A, DeAngelis C, Loblaw A, et al. 2009; Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study. Clin Oncol (R Coll Radiol). 21:329–35. DOI:
10.1016/j.clon.2008.12.010. PMID:
19232483.
5. Peters CM, Ghilardi JR, Keyser CP, Kubota K, Lindsay TH, Luger NM, et al. 2005; Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp Neurol. 193:85–100. DOI:
10.1016/j.expneurol.2004.11.028. PMID:
15817267.
6. Mantyh PW. 2006; Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci. 7:797–809. DOI:
10.1038/nrn1914. PMID:
16988655.
7. Obata K, Yamanaka H, Fukuoka T, Yi D, Tokunaga A, Hashimoto N, et al. 2003; Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats. Pain. 101:65–77. DOI:
10.1016/S0304-3959(02)00296-8. PMID:
12507701.
8. Habberstad R, Hjermstad MJ, Brunelli C, Kaasa S, Bennett MI, Pardon K, et al. 2019; Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses. Support Care Cancer. 27:1335–43. DOI:
10.1007/s00520-018-4405-9. PMID:
30105665.
9. Kerba M, Wu JS, Duan Q, Hagen NA, Bennett MI. 2010; Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy. J Clin Oncol. 28:4892–7. DOI:
10.1200/JCO.2010.28.6559. PMID:
20921451.
10. Lechner B, Chow S, Chow R, Zhang L, Tsao M, Danjoux C, et al. 2016; The incidence of neuropathic pain in bone metastases patients referred for palliative radiotherapy. Radiother Oncol. 118:557–61. DOI:
10.1016/j.radonc.2016.02.018. PMID:
26924340.
11. Nakamura N, Takahashi O, Zenda S, Kawamori J, Ogita M, Onozawa M, et al. 2016; Neuropathic pain features in patients with bone metastases. Clin Oncol (R Coll Radiol). 28:204–8. DOI:
10.1016/j.clon.2015.10.007. PMID:
26537667.
12. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. 2005; Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 114:29–36. DOI:
10.1016/j.pain.2004.12.010. PMID:
15733628.
13. Chaudakshetrin P. 2009; Validation of the Thai Version of Brief Pain Inventory (BPI-T) in cancer patients. J Med Assoc Thai. 92:34–40. PMID:
19260241.
14. Chinda M, Jaturapatporn D, Kirshen AJ, Udomsubpayakul U. 2011; Reliability and validity of a Thai version of the edmonton symptom assessment scale (ESAS-Thai). J Pain Symptom Manage. 42:954–60. DOI:
10.1016/j.jpainsymman.2011.02.020. PMID:
21621964.
15. Chaudakshetrin P, Prateepavanich P, Chira-Adisai W, Tassanawipas W, Leechavengvongs S, Kitisomprayoonkul W. 2007; Cross-cultural adaptation to the Thai language of the neuropathic pain diagnostic questionnaire (DN4). J Med Assoc Thai. 90:1860–5.
16. World Health Organization. 2018. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. World Health Organization;p. 21–49.
17. Falk S, Dickenson AH. 2014; Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol. 32:1647–54. DOI:
10.1200/JCO.2013.51.7219. PMID:
24799469.
20. Zhu XC, Zhang JL, Ge CT, Yu YY, Wang P, Yuan TF, et al. 2015; Advances in cancer pain from bone metastasis. Drug Des Devel Ther. 9:4239–45. DOI:
10.2147/DDDT.S87568. PMID:
26316696. PMCID:
PMC4547660.
21. Yang G, Luo Y, Baad-Hansen L, Wang K, Arendt-Nielsen L, Xie QF, et al. 2013; Ethnic differences in oro-facial somatosensory profiles-quantitative sensory testing in Chinese and Danes. J Oral Rehabil. 40:844–53. DOI:
10.1111/joor.12091. PMID:
23980926.
22. Zajacova A, Grol-Prokopczyk H, Fillingim R. 2022; Beyond Black vs White: racial/ethnic disparities in chronic pain including Hispanic, Asian, Native American, and multiracial US adults. Pain. 163:1688–99. DOI:
10.1097/j.pain.0000000000002574. PMID:
35250011.
23. Nekolaichuk CL, Fainsinger RL, Lawlor PG. 2005; A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton Classification System for Cancer Pain. Palliat Med. 19:466–76. DOI:
10.1191/0269216305pm1055oa. PMID:
16218159.
24. Mulvey MR, Bennett MI, Liwowsky I, Freynhagen R. 2014; The role of screening tools in diagnosing neuropathic pain. Pain Manag. 4:233–43. DOI:
10.2217/pmt.14.8. PMID:
24953075.
25. Mulvey MR, Boland EG, Bouhassira D, Freynhagen R, Hardy J, Hjermstad MJ, et al. 2017; Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles. Br J Anaesth. 119:765–74. DOI:
10.1093/bja/aex175. PMID:
29121284.
27. Forbes HJ, Thomas SL, Smeeth L, Clayton T, Farmer R, Bhaskaran K, et al. 2016; A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 157:30–54. DOI:
10.1097/j.pain.0000000000000307. PMID:
26218719. PMCID:
PMC4685754.
30. Steverink JG, Oostinga D, van Tol FR, van Rijen MHP, Mackaaij C, Verlinde-Schellekens SAMW, et al. 2021; Sensory innervation of human bone: an immunohistochemical study to further understand bone pain. J Pain. 22:1385–95. DOI:
10.1016/j.jpain.2021.04.006. PMID:
33964414.
32. Lautenbacher S, Peters JH, Heesen M, Scheel J, Kunz M. 2017; Age changes in pain perception: a systematic-review and meta-analysis of age effects on pain and tolerance thresholds. Neurosci Biobehav Rev. 75:104–13. DOI:
10.1016/j.neubiorev.2017.01.039. PMID:
28159611.
33. Richebé P, Capdevila X, Rivat C. 2018; Persistent postsurgical pain: pathophysiology and preventative pharmacologic considerations. Anesthesiology. 129:590–607. DOI:
10.1097/ALN.0000000000002238. PMID:
29738328.
35. Oostinga D, Steverink JG, van Wijck AJM, Verlaan JJ. 2020; An understanding of bone pain: a narrative review. Bone. 134:115272. DOI:
10.1016/j.bone.2020.115272. PMID:
32062002.
36. Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DLH, Bouhassira D, et al. 2016; Neuropathic pain: an updated grading system for research and clinical practice. Pain. 157:1599–606. DOI:
10.1097/j.pain.0000000000000492. PMID:
27115670. PMCID:
PMC4949003.
37. Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, et al. Classification Committee of the Neuropathic Pain Special Interest Group (NeuPSIG). 2019; The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 160:53–9. DOI:
10.1097/j.pain.0000000000001365. PMID:
30586071. PMCID:
PMC6310153.
38. Shkodra M, Brunelli C, Zecca E, Formaglio F, Bracchi P, Lo Dico S, et al. 2021; Neuropathic pain: clinical classification and assessment in patients with pain due to cancer. Pain. 162:866–74. DOI:
10.1097/j.pain.0000000000002076. PMID:
32947548. PMCID:
PMC7920493.
39. Brunelli C, Bennett MI, Kaasa S, Fainsinger R, Sjgren P, Mercadante S, et al. European Association for Palliative Care (EAPC) Research Network and International Association for the Study of Pain (IASP) Cancer Pain Special Interest Group. 2014; Classification of neuropathic pain in cancer patients: a Delphi expert survey report and EAPC/IASP proposal of an algorithm for diagnostic criteria. Pain. 155:2707–13. DOI:
10.1016/j.pain.2014.09.038. PMID:
25284070.
40. Bennett MI. 2011; Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliat Med. 25:553–9. DOI:
10.1177/0269216310378546. PMID:
20671006.
41. Nishihara M, Arai YC, Yamamoto Y, Nishida K, Arakawa M, Ushida T, et al. 2013; Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Physician. 16:E547–52. DOI:
10.36076/ppj.2013/16/E547. PMID:
24077205.
42. Tuchman M, Barrett JA, Donevan S, Hedberg TG, Taylor CP. 2010; Central sensitization and Ca(V)α₂δ ligands in chronic pain syndromes: pathologic processes and pharmacologic effect. J Pain. 11:1241–9. DOI:
10.1016/j.jpain.2010.02.024. PMID:
20472509.